Benzinga | Mar 4, 2021 04:00PM EST

Evofem Biosciences Q4 EPS $(0.50) Misses $(0.36) Estimate

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.36) by 38.89 percent. This is a 85.19 percent decrease over losses of $(0.27) per share from the same period last year.